Issues in the diagnosis of α1-antitrypsin deficiency

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 4, 2008, Pages 833-838

  Rachelefsky, Gary ^a   Hogarth, D Kyle ^b  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

1 Antitrypsin deficiency; augmentation therapy; diagnosis; genetic testing

Indexed keywords

ALPHA 1 ANTITRYPSIN; BRONCHODILATING AGENT; STEROID;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EMPHYSEMA; FORCED EXPIRATORY VOLUME; GENETIC ANALYSIS; GENOTYPE; HUMAN; LABORATORY TEST; LIFESTYLE MODIFICATION; LUNG FUNCTION TEST; LUNG RESECTION; LUNG TRANSPLANTATION; NOCICEPTIVE STIMULATION; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY REHABILITATION; THORAX RADIOGRAPHY;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; EMPHYSEMA; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 41449091857     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.12.1183     Document Type: Article

References (47)

1. 1-antitrypsin deficiency. Scand J Clin Lab Investigation 15 (1963) 132-140
2. Needham M., and Stockley R.A. Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax 59 (2004) 441-445
3. American Thoracic Society-European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 168 (2003) 818-900
4. World Health Organization. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ 75 (1997) 397-415
5. de Serres F.J. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 122 (2002) 1818-1829
6. de Serres F.J., Blanco I., and Fernandez-Bustillo E. Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening. COPD 3 (2006) 133-139
7. Campos M.A., Wanner A., Zhang G., and Sandhaus R.A. Trends in the diagnosis of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003. Chest 128 (2005) 1179-1186
8. Stoller J.K., and Aboussouan L.S. Alpha1-antitrypsin deficiency. Lancet 365 (2005) 2225-2236
9. Crystal R.G. Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest 85 (1990) 1343-1352
10. Dahl M., Tybjaerg-Hansen A., Lange P., Vestbo J., and Nordestgaard B.G. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 136 (2002) 270-279
11. Sveger T., Piitulainen E., and Arborelius Jr. M. Lung function in adolescents with alpha 1-antitrypsin deficiency. Acta Paediatr 83 (1994) 1170-1173
12. Thelin T., Sveger T., and McNeil T.F. Primary prevention in a high-risk group: smoking habits in adolescents with homozygous alpha-1-antitrypsin deficiency (ATD). Acta Paediatr 85 (1996) 1207-1212
13. Wall M., Moe E., Eisenberg J., Powers M., Buist N., and Buist A.S. Long-term follow-up of a cohort of children with alpha-1-antitrypsin deficiency. J Pediatr 116 (1990) 248-251
14. Bernspang E., Sveger T., and Piitulainen E. Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency. Respir Med 101 (2007) 1971-1976
15. Carpenter M.J., Strange C., Jones Y., Dickson M.R., Carter C., Moseley M.A., et al. Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency. Ann Behav Med 33 (2007) 22-28
16. Gitter AC, Jones Y, Schwartz L, Peterka L, Brantly M, Strange C. Confidential home alpha-1 antitrypsin testing: specialty center support for rare diseases. Presented at: ATS annual meeting; May 18-23, 2007; San Francisco, Calif.
17. Stoller J.K., Smith P., Yang P., and Spray J. Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey. Cleve Clin J Med 61 (1994) 461-467
18. Piitulainen E., and Sveger T. Effect of environmental and clinical factors on lung function and respiratory symptoms in adolescents with alpha1-antitrypsin deficiency. Acta Paediatr 87 (1998) 1120-1124
19. Piitulainen E., and Eriksson S. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). Eur Respir J 13 (1999) 247-251
20. Demeo D.L., Sandhaus R.A., Barker A.F., Brantly M.L., Eden E., McElvaney N.G., et al. Determinants of airflow obstruction in severe alpha 1- antitrypsin deficiency. Thorax 62 (2007) 806-813
21. Senn O., Russi E.W., Imboden M., and Probst-Hensch N.M. alpha1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants. Eur Respir J 26 (2005) 909-917
22. Alpha-1 Foundation. A healthcare provider's guide to alpha-1 antitrypsin deficiency. Version 1.6. Miami (FL): Alpha-1 Foundation; 2007.
23. Strange C., Stoller J.K., Sandhaus R.A., Dickson R., and Turino G. Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration 73 (2006) 185-190
24. McElvaney N.G., Stoller J.K., Buist A.S., Prakash U.B., Brantly M.L., Schluchter M.D., et al. Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group. Chest 111 (1997) 394-403
25. Hogarth DK. Testing for α1-antitrypsin deficiency in patients with asthma and/or chronic obstructive pulmonary disease: a surveillance study. Presented at: American College of Chest Physicians meeting; October 20-25, 2007; Chicago, Ill.
26. Sveger T., Ohlsson K., and Piitulainen E. Adolescents with alpha1-antitrypsin deficiency have high alpha2-macroglobulin and low neutrophil lipocalin and elastase levels in plasma. Pediatr Res 44 (1998) 939-941
27. Norman M.R., Mowat A.P., and Hutchison D.C. Molecular basis, clinical consequences and diagnosis of alpha-1 antitrypsin deficiency. Ann Clin Biochem 34 suppl (1997) 230-246
28. Sveger T., Thelin T., and McNeil T.F. Neonatal alpha1-antitrypsin screening: parents' views and reactions 20 years after the identification of the deficiency state. Acta Paediatr 88 (1999) 315-318
29. Sveger T., Thelin T., and McNeil T.F. Young adults with alpha 1-antitrypsin deficiency identified neonatally: their health, knowledge about and adaptation to the high-risk condition. Acta Paediatr 86 (1997) 37-40
30. Improving the implementation of alpha-1 diagnosis guidelines in clinical practice. Presented at: Advisory Forum; June 24-26, 2005; Las Vegas, Nev.
31. Brantly M.L., Wittes J.T., Vogelmeier C.F., Hubbard R.C., Fells G.A., and Crystal R.G. Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes. Chest 100 (1991) 703-708
32. Brantly M. Efficient and accurate approaches to the laboratory diagnosis of alpha1-antitrypsin deficiency: the promise of early diagnosis and intervention. Clin Chem 52 (2006) 2180-2181
33. Bals R., Koczulla R., Kotke V., Andress J., Blackert K., and Vogelmeier C. Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program. Respir Med 101 (2007) 1708-1714
34. Strange C., Moseley M.A., Jones Y., Schwarz L., Xie L., and Brantly M.L. Genetic testing of minors for alpha1-antitrypsin deficiency. Arch Pediatr Adolesc Med 160 (2006) 531-534
35. Snyder M.R., Katzmann J.A., Butz M.L., Yang P., Dawson D.B., Halling K.C., et al. Diagnosis of alpha-1-antitrypsin deficiency: an algorithm of quantitation, genotyping, and phenotyping. Clin Chem 52 (2006) 2236-2242
36. Alpha-1 Foundation. What is alpha-1 antitrypsin deficiency? Version 1 (1/06). Miami (FL): Alpha-1 Foundation; 2007.
37. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 (2007) 532-555
38. Dirksen A, Stockley RA, Piitulainen E, Shaker SB, Bernhardt T. A randomized, placebo-controlled, double-blind, exploratory study of the effect of augmentation therapy in patients with severe alpha-1 antitrypsin deficiency (AATD) and chronic obstructive pulmonary disease (COPD). Presented at: ATS annual meeting; May 18-23, 2007; San Francisco, Calif.
39. Louie S.G., Sclar D.A., and Gill M.A. Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency. Ann Pharmacother 39 (2005) 1861-1869
40. Seersholm N., Wencker M., Banik N., Viskum K., Dirksen A., Kok-Jensen A., et al. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Eur Respir J 10 (1997) 2260-2263
41. 1-proteinase inhibitor, Zemaira®. COPD 3 (2006) 17-23
42. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. Am J Respir Crit Care Med 158 (1998) 49-59
43. Wencker M., Fuhrmann B., Banik N., and Konietzko N. Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor. Chest 119 (2001) 737-744
44. Dirksen A., Dijkman J.H., Madsen F., Stoel B., Hutchison D.C., Ulrik C.S., et al. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med 160 (1999) 1468-1472
45. Parr D.G., Stoel B.C., Stolk J., and Stockley R.A. Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency. Thorax 61 (2006) 485-490
46. Trulock E.P., Edwards L.B., Taylor D.O., Boucek M.M., Keck B.M., and Hertz M.I. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report-2006. J Heart Lung Transplant 25 (2006) 880-892
47. Stoller J.K., Gildea T.R., Ries A.L., Meli Y.M., and Karafa M.T. Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency. Ann Thorac Surg 83 (2007) 241-251